drug discovery
Twist Bioscience Reports 17 Percent Growth of Fiscal Q4 Revenues, to Acquire Abveris
The firm has entered into a definitive agreement to acquire Abveris, an antibody discovery company, for up to $190 million in stock and cash.
The firm has revamped its business model to focus on AI-driven drug discovery and partnerships with pharma and academic cancer researchers.
Syntegra Teams With Vanderbilt's Nashville Biosciences on Biobank Data Analysis for Drug R&D
Data analysis firm Syntegra will work with NashBio to produce and validate synthetic data from the BioVU biobank, starting with type 2 diabetes.
ERS Genomics Licenses CRISPR Patents to Nuvisan
Nuvisan, based in Waltrop, Germany, will use ERS'w Genomics CRISPR-Cas9 portfolio to help advance its clients' drug discovery and early development programs.
Enpicom, Viroclinics-DDL Expand Partnership to Accelerate Antibody, Vaccine Discovery
A Dutch province has awarded an unspecified sum to the Netherlands-based firms to combine their technologies for TCR and BCR repertoire sequencing and analysis.
Mar 17, 2021
Feb 19, 2021
Nov 23, 2020
Oct 29, 2020
Oct 7, 2020
Jul 13, 2020
Jul 9, 2020
Jun 11, 2020